The Efficacy of Dupilumab Largely Exceeds the 6-Month Treat-to-target Goals: An Analysis in an Atopic Dermatitis Referral Center

Valente CFigueira Vilela BPaiva-Lopes MJDuarte B2025-08-262025-08-262025Actas Dermosifiliogr. 2025 Jul-Aug;116(7):778-780http://hdl.handle.net/10400.17/5144engDupilumabAtopic DermatitisHSAC DERThe Efficacy of Dupilumab Largely Exceeds the 6-Month Treat-to-target Goals: An Analysis in an Atopic Dermatitis Referral Centertext10.1016/j.ad.2023.10.062